Dr. Berenson is the Founder and Principal of the Berenson Cancer Center, a unique multi-faceted business entity built around an established and integrated healthcare and biotech family of companies.
These consist of:
He also is the Founder, President, and Medical and Scientific Director of the Institute for Myeloma & Bone Cancer Research (IMBCR):Â A missionâ€‘driven 501(C)3 non-profit institute dedicated to the discovery of novel treatments for multiple myeloma and related conditions in a preâ€‘clinicalÂ in vitro and in vivoÂ research laboratory and includes an extensive biobank with long-term clinical samples.
Dr. Berenson has authored nearly 300 peer-reviewed publications and contributed to multiple book chapters. He has served as a member of the National Institutes of Health â€“ Center for Scientific Review, Clinical Oncology Study Section and has been a member of the Scientific Boards of the Multiple Myeloma Research Foundation and the International Myeloma Foundation. Dr.Â Berenson has served on both the Foundation and the Scientific Boards of the Leukemia, Lymphoma and Myeloma Society. He also serves on the Scientific Board of the International Waldenstromsâ€™ Macroglobulinemia Foundation.